This study is in progress, not accepting new patients
A Phase III Study to Evaluate the Port Delivery System With Ranibizumab Compared With Monthly Ranibizumab Injections in Participants With Wet Age-Related Macular Degeneration
Summary
- Eligibility
- for people ages 50 years and up (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
- Principal Investigator
- by Robert Bhisitkul
Description
Summary
Official Title
Keywords
Eligibility
Locations
Lead Scientist at UCSF
- Robert Bhisitkul
Professor, Ophthalmology. Authored (or co-authored) 56 research publications.
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Hoffmann-La Roche
- ID
- NCT03677934
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated